In a cross-sectional epidemiological study including 3290 men aged 53-75 y, mean ¼ 63, we tested the hypothesis that the Lewis phenotype Le(aÀbÀ) is a genetic marker of obesity. All men were Lewis typed and measurements were made of height, weight, neck circumference, and hip fat fold. Obesity was defined as a body mass index Z30 kg/m 2 . Totally 291 men (8.8%) were obese; 9.6% of the men had the Le(aÀbÀ) phenotype. Le(aÀbÀ) men had a higher prevalence of obesity than others, 15.6 vs 8.1%, odds ratio (95% confidence interval): 2.1(1.5-2.9), Po0.001. The etiological fraction, that is, the excess prevalence of obesity in the study population due to the Le(aÀbÀ) phenotype, was approximately 10%. The frequency of the Le(aÀbÀ) phenotype may vary substantially in different populations. Identification of this new genetic marker of obesity may, for example, contribute to the explanation of individual and ethnic differences in the prevalence of obesity.
Introduction
In 1946, Mourant identified the first Lewis blood group antigen Le a. Later antigen Le b was discovered, and the four Lewis phenotypes: Le(aÀbÀ), Le(a þ bÀ), Le(aÀb þ ) and Le(a þ b þ ) were established. 1 The phenotype expression is determined by two genetic systems closely related on the short arm of chromosome 19, the Lewis genes Le and le, and the Secretor genes, Se and se. The gene product consists of various fucosyl transferases, which from tissue liquids are adsorbed onto cell surfaces. 1 Le(aÀbÀ) individuals lack alpha (1,3/1,4) fucosyltransferase activity. 2 Almost 10% belong to this phenotype in the Danish as well as in most other Caucasian populations. 1 It has been shown, that Le(aÀbÀ) subjects have a slightly higher mean body mass index, 3 a higher weight gain over time, 4 a higher prevalence and incidence of ischemic heart disease, 3,5,6 a higher prevalence of type 2 diabetes, 7 and a higher prevalence of features of the insulin resistance syndrome. 8 A study focusing specifically on the possible association between Lewis phenotypes and obesity is lacking. The above listed observations suggest that the Le(aÀbÀ) phenotype may be a genetic marker of obesity. We tested this hypothesis.
Subjects
The Copenhagen Male Study (CMS) was established in 1970/ 1971 as a prospective cardiovascular cohort study originally including 5249 Caucasian men with a mean age of 48 y (range 40-59). 9 In 1985/1986 a new baseline was established. [3] [4] [5] [6] Participants from the 1970/1971 study were traced by means of the Danish Central Population Register. All survivors (except 34 emigrants) from the original cohort were invited to take part in this study. Totally 3387 men (75%) agreed and gave informed consent; their mean age was 63 y (range 53-75).
Methods
The 10, 11 Odds ratios were calculated by taking the natural log e raised to the regression coefficient for the variable of interest in a multiple logistic regression model. For all analyses, a two-sided probability value of Po0.05 was a priori taken as statistically significant. Table 1 presents the number and proportion of Lewis phenotypes in [1985] [1986] , and the distribution of obesity and weight characteristics among men with the Le(aÀbÀ) phenotype and men with other Lewis phenotypes. Compared to other men, Le(aÀbÀ) men had a two-fold higher prevalence of obesity, odds ratio with 95% confidence limits was 2.1(1.5-2.9). Thus, almost one out of six men were obese in this group vs one out of 12 among men with other Lewis phenotypes. Neck circumference and fat fold measures were slightly and nonsignificantly higher in Le(aÀbÀ) men. Figure 1 shows the prevalence of obesity in 1985-1986 according to Lewis phenotype within three age strata using tertiles as cutoff points. In all age groups, the prevalence of obesity was higher among men with the Le(aÀbÀ) phenotype.
Results
The population etiological fraction
of obesity due to Le(aÀbÀ) could be estimated to be approximately 10% (not shown in tables).
Finally, to ascertain the relevance of BMI as a marker of obesity, we calculated correlation coefficients (Spearman's Rho) between BMI and fat fold, and between BMI and neck circumference. BMI was strongly associated with both factors, with coefficients of 0.68, Po0.001, and 0.75, Po0.001, respectively.
Discussion
This study is the first to show that Le(aÀbÀ) is a genetic marker of obesity. Middle aged and elderly men with the Le(aÀbÀ) had a two-fold higher prevalence of obesity compared to men with other Lewis phenotypes.
Selection bias is a major potential source of systematic error and should be addressed. Several observations make selection bias an unlikely explanation for our findings. (1) (Figure 1 ). The population attributable risk associated with the Lewis blood group may vary substantially between different populations due to large ethnic variations in Lewis phenotype distribution; for example, in the Danish and most other Caucasian populations a little less than 10% belong to the Le(aÀbÀ) phenotype, whereas in African Americans almost 30% and in Africans as many as 40% may belong to the Le(aÀbÀ) phenotype. 1 In conclusion, identification of the Le(aÀbÀ) phenotype as a new genetic marker of obesity may contribute to an explanation of individual and ethnic differences in the prevalence of obesity, opening up possibilities to detect new gene-environment interactions.
